IQVIA
Deep Dive/ Market Access/ Views & Analysis/ Views and analysis
Research predicts the post-COVID landscape for HCP engagement
mike.hammerton@pharmaphorum.com
COVID-19, Deep Dive, Deep Dive: Market Access, IQVIA, Liz Murray, market access
0 Comment
Deep Dive/ Market Access/ Views & Analysis/ Views and analysis
A year on: pandemic driven trends in HCP engagement
mike.hammerton@pharmaphorum.com
Deep Dive, Deep Dive: Market Access, HCP, IQVIA, market access, pandemic
0 Comment
Market Access/ Views & Analysis/ Views and analysis
Three pillars of post-pandemic launch excellence
R&D/ Views & Analysis/ Views and analysis
Unlocking health data to improve oncology outcomes
Dominic Tyer
cancer care, COVID-19, Health data, IQVIA, NHS, NICE, Real World Evidence
0 Comment
Deep Dive/ Patients/ Views & Analysis/ Views and analysis
Enabling new models of care: pursuing pharma’s partnership potential
mike.hammerton@pharmaphorum.com
Deep Dive, IQVIA, NHS, patients, Patients and Partnerships 2020, Stephen Jowett
0 Comment
Market Access/ Views & Analysis/ Views and analysis
Nine for 2021: The COVID-19 legacy
Catherine Longworth
2021, COVID-19, IQVIA, Nine for 2021, pandemic, Sarah Rickwood
0 Comment
UK initiative aims to cut COVID-19 drug development to a few weeks
Richard Staines
BerGenBio, coronavirus, COVID-19, IQVIA, R&D
0 Comment
Debates/ Oncology/ Webinars/ Webinars On demand
Unlocking health data to improve oncology outcomes
louise.bellamy@pharmaphorum.com
DATA-CAN, Health data, health outcomes, IQVIA, Oncology, oncology research, patient outcomes, simulated data
0 Comment